Prognostic evaluation of copd patients: Gold 2011 versus bode and the copd comorbidity index cote

Thorax

Volumn 69, Issue 9, 2014, Pages 799-804

  De Torres, Juan P ^a   Casanova, Ciro ^b   Marín, Jose M ^c   Pinto Plata, Victor ^d   Divo, Miguel ^d   Zulueta, Javier J ^a   Berto, Juan ^a   Zagaceta, Jorge ^a   Sanchez Salcedo, Pablo ^a   Cabrera, Carlos ^d   Carrizo, Santiago ^c   Cote, Claudia ^e   Celli, Bartolome R ^f  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^d HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^e Bay Pines VA Medical Center   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; BMI OBSTRUCTION DYSPNEA EXERCISE INDEX; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; COPD COMORBIDITY TEST INDEX; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; EXERCISE; FEMALE; GLOBAL OBSTRUCTIVE LUNG DISEASE 2011 INDEX; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; SEVERITY OF ILLNESS INDEX; SPAIN; STATISTICAL ANALYSIS; SURVIVAL PREDICTION; UNITED STATES;

COPD PATHOLOGY;

AGED; AREA UNDER CURVE; COMORBIDITY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84905967951     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-205770     Document Type: Article

References (21)

1. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-65.
2. Rabe KF, Hurd S, Anzueto A, et al.; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55. (Pubitemid 47403272)
3. Celli BR, Cote C, Marin JM, et al. The Body Mass Index, Airflow Obstruction, Dyspnea, Exercise Performance (BODE) index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12. (Pubitemid 38269277)
4. Martinez FJ, Foster G, Curtis JL, et al.; NETT Research Group. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006;173:1326-34. (Pubitemid 43900706)
5. Marin JM, Cote CG, Diaz O, et al. Prognostic assessment in COPD: health related quality of life and the BODE index. Respir Med 2011;105:916-21.
6. Cote CG, Celli BR. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 2005;26:630-6. (Pubitemid 41448660)
7. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. (Pubitemid 17055592)
8. Divo M, Cote C, de Torres JP, et al.; BODE Collaborative Group. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;186:155-61.
9. Soriano JB, Alfageme I, Almagro P, et al. Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classification. Chest 2013;143:694-702.
10. Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 2012;186:975-81.
11. Agusti A, Edwards LD, Celli B, et al.; ECLIPSE Investigators. Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. Eur Respir J 2013;42:636-46.
12. Johannessen A, Nilsen RM, Storebø M, et al. Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease Guidelines for Predicting Mortality and Hospitalization. Am J Respir Crit Care Med 2013;188:51-9.
13. Leivseth L, Brumpton BM, Lund Nilsen TI, et al. GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway. Thorax 2013;68:914-21.
14. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46. (Pubitemid 38807371)
15. Mahler D, Weels C. Evaluation of clinical methods for rating dyspnea. Chest 1988;93:580-6.
16. Agusti A, Hurd S, Jones P, et al. FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts. Eur Respir J 2013;42:1391-401.
17. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009;34:648-54.
18. van der Molen T, Willemse BW, Schokker S, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:13.
19. Casanova C, Marin JM, Martinez-Gonzalez C, et al.; COPD History Assessment In Spain (CHAIN) Cohort. New GOLD classification: longitudinal data on group assignment. Respir Res 2014;15:3.
20. Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002;121: 1434-40. (Pubitemid 34499652)
21. de Torres JP, Cote CG, López MV, et al. Sex differences in mortality in patients with COPD. Eur Respir J 2009;33:528-35.